__NUXT_JSONP__("/drugs/Tretinoin", (function(a,b,c,d,e,f,g,h,i,j,k){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[{brand:a,indication:e,manufacturer:f,splSetId:"00892887-ad81-414d-a388-08716235fa2c"},{brand:a,indication:b,manufacturer:"Major Pharmaceuticals",splSetId:"045258e2-5efb-4147-bf74-4c43af04dccc"},{brand:g,indication:"1 INDICATIONS AND USAGE Retin-A Micro ® is a retinoid indicated for topical application in the treatment of acne vulgaris. Retin-A Micro is a retinoid, indicated for topical treatment of acne vulgaris. ( 1 )",manufacturer:"Bausch Health US LLC",splSetId:"08ab7e0c-1437-455f-815c-98904d96a289"},{brand:c,indication:h,manufacturer:"A-S Medication Solutions",splSetId:"0a6722ba-c2e5-4d7a-82ea-bcd6a54033b5"},{brand:"VELTIN",indication:"1 INDICATIONS AND USAGE VELTIN™ (clindamycin phosphate and tretinoin) Gel, 1.2%\u002F0.025% is indicated for the topical treatment of acne vulgaris in patients 12 years and older. • VELTIN™ Gel is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years and older. ( 1 )",manufacturer:"Almirall, LLC",splSetId:"0dad9bef-cfcc-4216-86c8-9ccd6b8613d8"},{brand:a,indication:e,manufacturer:"Teva Pharmaceuticals USA, Inc.",splSetId:"0f81f505-a962-414e-8612-c3ef3b159e9a"},{brand:"Altreno",indication:"1 INDICATIONS AND USAGE ALTRENO ® (tretinoin) lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. ALTRENO is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. (1)",manufacturer:i,splSetId:"1412aba5-71aa-4cce-8db4-c189bed1852c"},{brand:a,indication:"INDICATIONS AND USAGE Tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and\u002For the presence of the PML\u002FRARα gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin is for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and\u002For maintenance therapy for APL after completion of induction therapy with tretinoin.",manufacturer:"Glenmark Pharmaceuticals Inc., USA",splSetId:"264138c1-9e5f-45ef-be87-79ca97c989d9"},{brand:a,indication:"Indications and Usage Tretinoin cream is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.",manufacturer:"Taro Pharmaceuticals U.S.A., Inc.",splSetId:"2b0c8ee4-83a5-48f1-809a-9716131f7290"},{brand:d,indication:"INDICATIONS AND USAGE AVITA ® Cream is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of this product in the treatment of other disorders have not been established.",manufacturer:j,splSetId:"302ca95f-5a7e-4971-870a-5cfea618d7a7"},{brand:c,indication:h,manufacturer:"Padagis US LLC",splSetId:"4889c7f8-37d0-4f1a-9829-bca107806586"},{brand:"Clindamycin Phosphate 1.2% and Tretinoin 0.025%",indication:"1 INDICATIONS AND USAGE Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older. Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years or older. ( 1 )",manufacturer:"Oceanside Pharmaceuticals",splSetId:"63b2e85d-8fe5-4f18-9e85-8492c49a7520"},{brand:d,indication:"INDICATIONS AND USAGE AVITA ® Gel is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of this product in the treatment of other disorders have not been established.",manufacturer:j,splSetId:"6bb07b84-68bd-4513-b0cf-e2e949eaa964"},{brand:a,indication:b,manufacturer:"AvKARE, Inc.",splSetId:"6f8c2985-0241-5ebf-7ed4-4bd9a4ead9c9"},{brand:"Tretinoin Cream",indication:"INDICATIONS AND USAGE Tretinoin is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.",manufacturer:"Obagi Cosmeceuticals LLC",splSetId:"745cc3ce-60b4-4479-a055-316817567949"},{brand:"ZIANA",indication:"1 INDICATIONS AND USAGE ZIANA Gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older. ZIANA ® Gel is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years or older. ( 1 )",manufacturer:i,splSetId:"78c329f9-f0c9-486d-9e54-0123699fb9e1"},{brand:"Clindamycin Phosphate and Tretinoin",indication:"1 INDICATIONS & USAGE Clindamycin phosphate and tretinoin gel 1.2% \u002F 0.025% is indicated for the topical treatment of acne vulgaris in patients 12 years or older. Clindamycin phosphate and tretinoin gel 1.2% \u002F 0.025% is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years or older. ( 1 )",manufacturer:"Actavis Pharma, Inc.",splSetId:"79e1c8f6-59cd-4efa-9efa-0762d4b1a10c"},{brand:a,indication:b,manufacturer:f,splSetId:"844941d4-f557-42cf-b7fa-5bd7574925f6"}],id:a,nciThesaurus:{casRegistry:"302-79-4",chebiId:"CHEBI:15367",chemicalFormula:"C20H28O2",definition:"A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis.  This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types.  The oral form of tretinoin has teratogenic and embryotoxic properties.",fdaUniiCode:"5688UTC01R",identifier:"C900",preferredName:a,semanticType:"Organic Chemical",subclassOf:[],synonyms:["(All-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid","2,4,6,8-Nonatetraenoic acid, 3, 7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-","ATRA","Aberel","Airol","Aknoten","All-trans Retinoic Acid","All-trans Vitamin A Acid",d,"Cordes Vas","Dermairol","Epi-Aberel","Eudyna","Renova","Retin-A",g,"Retin-A-Micro","Retinoic Acid","Retisol-A","Ro 5488","Stieva-A","Stieva-A Forte",c,"Trans Retinoic Acid","Trans Vitamin A Acid",a,"Tretinoinum","Vesanoid","Vitamin A Acid","Vitamin A acid","Vitamin A acid, all-trans-","Vitinoin","all trans-Retinoic acid","all-trans retinoic acid","all-trans-Retinoic acid","all-trans-Vitamin A acid","beta-Retinoic Acid","retinoic acid","trans-Retinoic Acid","trans-Retinoic acid","tretinoin","vitamin A acid"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FTretinoin",extension:".json",createdAt:k,updatedAt:k}}],fetch:{},mutations:void 0}}("Tretinoin","INDICATIONS AND USAGE Tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and\u002For the presence of the PML\u002FRARα gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin capsules are for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and\u002For maintenance therapy for APL after completion of induction therapy with tretinoin capsules.","TRETINOIN","Avita","INDICATIONS AND USAGE Tretinoin Capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and\u002For the presence of the PML\u002FRARα gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline based chemotherapy is contraindicated. Tretinoin is for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and\u002For maintenance therapy for APL after completion of induction therapy with tretinoin.","Bryant Ranch Prepack","Retin-A MICRO","Indications and Usage: Tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.","Bausch Health US, LLC","Mylan Pharmaceuticals Inc.","2021-10-30T13:47:02.053Z")));